|
1
|
Lydiatt WM, Patel SG, O'Sullivan B,
Brandwein MS, Ridge JA, Migliacci JC, Loomis AM and Shah JP: Head
and neck cancers-major changes in the American joint committee on
cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:122–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kumar M, Nanavati R, Modi TG and Dobariya
C: Oral cancer: Etiology and risk factors: A review. J Cancer Res
Ther. 12:458–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ghantous Y and Abu Elnaaj I: Global
incidence and risk factors of oral cancer. Harefuah. 156:645–649.
2017.(In Hebrew). PubMed/NCBI
|
|
5
|
Rivera C: Essentials of oral cancer. Int J
Clin Exp Pathol. 8:11884–11894. 2015.PubMed/NCBI
|
|
6
|
Ram H, Sarkar J, Kumar H, Konwar R, Bhatt
ML and Mohammad S: Oral cancer: Risk factors and molecular
pathogenesis. J Maxillofac Oral Surg. 10:132–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brocklehurst P, Kujan O, O'Malley LA,
Ogden G, Shepherd S and Glenny AM: Screening programmes for the
early detection and prevention of oral cancer. Cochrane Database
Syst Rev. CD0041502013.PubMed/NCBI
|
|
8
|
Mishra R: Glycogen synthase kinase 3 beta:
Can it be a target for oral cancer. Mol Cancer. 9:1442010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Molinolo AA, Marsh C, El Dinali M, Gangane
N, Jennison K, Hewitt S, Patel V, Seiwert TY and Gutkind JS: mTOR
as a molecular target in HPV-associated oral and cervical squamous
carcinomas. Clin Cancer Res. 18:2558–2568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohnishi Y, Yasui H, Nozaki M and Nakajima
M: Molecularly-targeted therapy for the oral cancer stem cells. Jpn
Dent Sci Rev. 54:88–103. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Z, Wu P, Su M, Ling H, Khoshaba R,
Huang C, Gao H, Zhao Y, Chen J, Liao Q, et al: Long non-coding RNA
UASR1 promotes proliferation and migration of breast cancer cells
through the AKT/mTOR pathway. J Cancer. 10:2025–2034. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y,
Yao H, Liu X, Ke Y, Si J and Zhou T: MiR-375 frequently
downregulated in gastric cancer inhibits cell proliferation by
targeting JAK2. Cell Res. 20:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tirelli G, Gatto A, Boscolo Nata F,
Bussani R, Piccinato A, Marcuzzo AV and Tofanelli M: Prognosis of
oral cancer: A comparison of the staging systems given in the 7th
and 8th editions of the American Joint Committee on Cancer Staging
Manual. Br J Oral Maxillofac Surg. 56:8–13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jairajpuri ZS, Rana S, Hajela A and Jetley
S: Toward early diagnosis of oral cancer: Diagnostic utility of
cytomorphological features, a pilot study. Natl J Maxillofac Surg.
10:20–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu Y, Sun X, Song B, Qiu X and Zhao J:
MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma
proliferation and invasion. Cancer Med. 6:1686–1697. 2017.
View Article : Google Scholar : PubMed/NCBI
|
